These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Gasse C, Huteau V, Douguet D, Munier-Lehmann H, Pochet S. Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536 [No Abstract] [Full Text] [Related]
3. Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Vanheusden V, Munier-Lehmann H, Froeyen M, Busson R, Rozenski J, Herdewijn P, Van Calenbergh S. J Med Chem; 2004 Dec 02; 47(25):6187-94. PubMed ID: 15566289 [Abstract] [Full Text] [Related]
4. Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. Vanheusden V, Van Rompaey P, Munier-Lehmann H, Pochet S, Herdewijn P, Van Calenbergh S. Bioorg Med Chem Lett; 2003 Sep 15; 13(18):3045-8. PubMed ID: 12941330 [Abstract] [Full Text] [Related]
5. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors. Andrade CH, Pasqualoto KF, Ferreira EI, Hopfinger AJ. J Chem Inf Model; 2009 Apr 15; 49(4):1070-8. PubMed ID: 19296716 [Abstract] [Full Text] [Related]
6. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. Familiar O, Munier-Lehmann H, Negri A, Gago F, Douguet D, Rigouts L, Hernández AI, Camarasa MJ, Pérez-Pérez MJ. ChemMedChem; 2008 Jul 15; 3(7):1083-93. PubMed ID: 18418833 [Abstract] [Full Text] [Related]
7. Synthesis and evaluation of thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. Vanheusden V, Munier-Lehmann H, Pochet S, Herdewijn P, Van Calenbergh S. Bioorg Med Chem Lett; 2002 Oct 07; 12(19):2695-8. PubMed ID: 12217356 [Abstract] [Full Text] [Related]
8. Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase. Van Poecke S, Munier-Lehmann H, Helynck O, Froeyen M, Van Calenbergh S. Bioorg Med Chem; 2011 Dec 15; 19(24):7603-11. PubMed ID: 22061826 [Abstract] [Full Text] [Related]
10. Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase. Van Calenbergh S. Verh K Acad Geneeskd Belg; 2006 Dec 15; 68(4):223-48. PubMed ID: 17214439 [Abstract] [Full Text] [Related]
11. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity. Gasse C, Douguet D, Huteau V, Marchal G, Munier-Lehmann H, Pochet S. Bioorg Med Chem; 2008 Jun 01; 16(11):6075-85. PubMed ID: 18467107 [Abstract] [Full Text] [Related]
12. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase. Van Calenbergh S, Pochet S, Munier-Lehmann H. Curr Top Med Chem; 2012 Jun 01; 12(7):694-705. PubMed ID: 22283813 [Abstract] [Full Text] [Related]
19. Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans. Pochet S, Dugué L, Labesse G, Delepierre M, Munier-Lehmann H. Chembiochem; 2003 Aug 04; 4(8):742-7. PubMed ID: 12898625 [Abstract] [Full Text] [Related]